Skip to main content
. Author manuscript; available in PMC: 2020 Sep 1.
Published in final edited form as: Arterioscler Thromb Vasc Biol. 2019 Jun 6;39(9):1747–1761. doi: 10.1161/ATVBAHA.119.312382

Figure 2.

Figure 2.

In vivo catabolism and RCT of plasma HDL CO. 3H-CO radiolabeled human HDL was injected intravenously in control (n=6) and HSKO (n=6) mice with 125I-TC HDL (see Figure 1). Periodic blood samples were taken over 24 or 48 hours in two separate experiments to analyze plasma decay (A), plasma FCR (B), plasma HDL 3H-CO selective clearance, using data from Figure 1B for 125I-TC FCR (C), liver 3H-radiolabel accumulation (D), and fecal 3H-radiolabel excretion (E). Data are mean ± SEM. Control turnover curves in panel A are nearly identical and SEM in nearly all points falls within the symbol. **p < 0.01; ***p < 0.001.